Alnylam Pharmaceuticals
ALNY
#638
Rank
S$41.81 B
Marketcap
$324.23
Share price
-3.51%
Change (1 day)
30.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company